awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38118053-1C755197-A9A6-4F8A-852F-05A5835362CE
Q38118053-1C755197-A9A6-4F8A-852F-05A5835362CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38118053-1C755197-A9A6-4F8A-852F-05A5835362CE
Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews.
P2860
Q38118053-1C755197-A9A6-4F8A-852F-05A5835362CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38118053-1C755197-A9A6-4F8A-852F-05A5835362CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1836af7042d732ce4971f44a66d8ac3638f07bc1
P2860
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.